Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Antengene and MindRank AI Enter into Collaboration to Advance the Development of Difficult-to-Drug Molecular Targets 2021-08-09 08:30
China NMPA Approves Phase II Clinical Trial of ASC40 for the Treatment of Patients with Acne 2021-08-09 08:30
Innovent Announces the Establishment of the Scientific Advisory Board 2021-08-09 08:04
Insightec Announces Seoul National University Hospital Is Installing Exablate Neuro Platform 2021-08-09 08:00
NUH's Smallest Surviving Baby Discharged Well to Home 2021-08-07 15:00
FibroBiologics Announces Inaugural Board of Directors 2021-08-06 22:01
Endurance Longevity Announces Positive Profit Alert for Interim Results 2021 and Other Exciting Business Updates 2021-08-06 20:02
ImmVira's MVR-T3011 Obtained NMPA's Approval for Intravenous Administration (IV) Phase I Clinical Trial 2021-08-06 19:50
AI and Big Data Join Hands to Assist Physicians in Diagnosis and Reporting 2021-08-06 17:00
ORI Capital's Portfolio Company Pillar Receives FDA Premarket Approval for its oncoReveal(TM) Dx Lung and Colon Cancer Test 2021-08-06 12:56
Penpulimab Monoclonal Antibody (PD-1) Obtains Marketing Approval in China 2021-08-06 09:39
SURGLASSES' SPINE NAVIGATION SYSTEM CADUCEUS S - An innovation greatly influencing minimally invasive surgeries 2021-08-06 08:00
Updated Overall Survival Data and Biomarker Results from Sintilimab ORIENT-11 Study in First-Line Nonsquamous Non-Small Cell Lung Cancer Published in the Journal of Thoracic Oncology 2021-08-06 08:00
Novavax Announces COVID-19 Vaccine Booster Data Demonstrating Four-Fold Increase in Neutralizing Antibody Levels Versus Peak Responses After Primary Vaccination 2021-08-06 05:03
Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Vaccine 2021-08-06 04:41
Advanced Instruments to Acquire Solentim, a Trusted Global Leader in Cell Imaging for Cell Line Development and Clone Characterization 2021-08-06 02:00
Brii Biosciences Announces the Completion of Enrollment in the Phase 3 National Institutes of Health (NIH) ACTIV-2 Trial, Evaluating the BRII-196 and BRII-198 Monoclonal Neutralizing Antibody Combination for the Treatment of COVID-19 2021-08-05 22:46
ArisGlobal Lauded by Frost & Sullivan for Enabling Life Sciences Companies to Accelerate R&D with Its LifeSphere® Platform 2021-08-05 21:55
China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval 2021-08-05 21:00
Berry Oncology Completes Series B1 Funding, Attracting Most Venture Capital to Date in Early Cancer Screening Sector 2021-08-05 21:00
1 358 359 360 361 362 892